Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences In Silico Drug Discovery and Predictive Toxicology 2016

In Silico Drug Discovery and Predictive Toxicology 2016

Date: Thursday, 29 September 2016 - Friday, 30 September 2016
Location: San Diego, California, USA

Keynote Speakers

Eric Martin

Eric Martin
Director, Computational Chemistry, Novartis

Shahar Keinan

Shahar Keinan
Chief Scientific Officer, Cloud Pharmaceuticals


The Second Annual In Silico Drug Discovery & Predictive Toxicology 2016 Conference aims to bring multi-disciplinary research that leverages computer simulations and algorithms and address key questions in computational drug discovery as well as predictive toxicology performed in vitro.  Both in silico and wet biology approaches will be presented and discussed at this conference enabling a complete and up-to-date picture of this evolving space to be presented.

It is widely recognized that traditional drug discovery and development are spiraling out of control with increased costs and lower success rates. If the vision of precision medicine and eventually personalized medicine is to happen, it is important that new breakthroughs and better applications emerge for computational drug discovery and these synergize within the workflow of the drug discovery process.

In particular, this conference will feature sessions focusing on the development and application of novel and state-of-the-art computational tools and technologies for drug discovery as well as technologies for toxicity screening/predictive tox.

Agenda Topics

  • ADME Optimization for Drug Design/Discovery
  • ADME/Tox Prediction
  • Automatic Scaffold Design and Scaffold Hopping
  • Big Data Challenges in Predictive Toxicology
  • Collaborative Drug Discovery and Secure Information Sharing
  • Computational Approaches for Fragment-based Drug Discovery
  • Computer-aided Drug Design (CADD)
  • Intellectual Property Issues Arising from In Silico Discovery
  • Pharmacogenomics and Drug Safety
  • QM/MM, Molecular Dynamics and Free Energy Methods
  • Regulatory Issues in ADME
  • Systems Biology Considerations and Target Validation
  • Virtual Screening Methods

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager

Confirmed Speakers to date

Ed Addison, CEO, Cloud Pharmaceuticals, Inc.
Nigel Beeley, Advocate, Collaborative Drug Discovery (CDD)
Rae Lawrence, Technical Sales, Cresset
Vicki Nienaber, CSO, Zenobia Therapeutics, Inc.
Marie Willemin, Research Fellow, National Center for Toxicology Research, US Food and Drug administration (FDA)

Corporate Sponsors Media Sponsors Networking

Add to Calendar ▼2016-09-29 00:00:002016-09-30 00:00:00Europe/LondonIn Silico Drug Discovery and Predictive Toxicology 2016In Silico Drug Discovery and Predictive Toxicology 2016 in San Diego, California, USASan Diego, California,